Angst MS, Clark JD. Opioid-induced hyperalgesia: a quantitative systematic review. Anesthesiology. 2006;104:570-587.

Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24:479-496.

DuPen A, Shen D, Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Mange Nurs. 2007;8:113-121.

Guignard B, Bossard AE, Coste C. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93:409-417.

Reznikov I, Pud D, Eisenberg E. Oral opioid administration and hyperalgesia inpatients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol. 2005;60:311-318.

Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002;100:213-217.

Vanderah TW, Ossipov MH, Lai J. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain. 2001;92:5-9.

Schmidt S, Bethge C, Förster M. Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin J Pain. 2007;23:605-611.

Joly V, Richebe P, Guignard B. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 2005;103:147-155.

Célèrier E, Rivat C, Jun Y. Long-lasting hyperalgesia induced by fentanyl in. .

Collett BJ. Opioid tolerance: the clinical perspective. Br J Anaesth. 1998;81:58-68.

Bruera E, MacMillan K, Hanson J. The Edmonton staging system for cancer pain: preliminary report. Pain. 1989;37:203-209.

Jage J. Opiod tolerance and dependence: do they matter?. Eur J Pain. 2005;9:157-162.

Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain?. Neuroreport. 2003;14:1-7.

Ossipov MH, Lai J, King T. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers. 2005;80:319-324.

Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev. 2004;27:729-737.

Liang D, Shi X, Qiao Y. Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision. Mol Pain. 2008;4.

Mogil JS, Wilson SG, Chesler EJ. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA. 2003;100:4867-4872.

Hood D, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-Induced hiperalgesia. Anesth Analg. 2003;97:810-815.

Cortinez LI, Brandes V, Munoz HR. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth. 2001;87:866-869.

Koppert W, Schmelz M. The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract Res Clin Anaesthesiol. 2007;21:65-83.

Guntz E, Talla G, Roman A. Opioid-induced hiperalgesia. Eu J Anaesthesiol. 2007;24:205-207.

Davis MP, Shaiova LA, Angst MS. When opioids cause pain. J Clin Oncol. 2007;25:4497-4498.

Doverty M, White JM, Somogyi A. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90:91-96.

Yaksh TL, Harty GJ. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther. 1988;244:501-507.

Kissin I, Brown PT, Bradley EL. Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology. 1991;75:813-816.

Kissin I, Brown PT, Robinson CA. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology. 1991;74:166-171.

Crawford MW, Hickey C, Zaarour C. Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth Analg. 2006;102:1662-1667.

Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg. 1998;86:1307-1311.

Koppert W, Angst M, Alsheimer M. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentail in humans. Pain. 2003;106:91-99.

Rivat C, Laulin JP, Corcuff JB. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology. 2002;96:381-391.

Ali NM. Hyperalgesic response in a patient receiving high concentrations of spinal morphine. Anesthesiology. 1986;65:449-450.

Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 1995;62:259-274.

Singler B, Tröster A, Manering N. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg. 2007;104:1397-1403.

DeKock MF, Lavand'homme PM. The clinical role of NMDA receptor antagonist for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol. 2007;21:85-98.

Guignard B, Coste C, Costes H. desfluraneremifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth Analg. 2002;95:103-108.

Engelhardt T, Zaarour C, Naser B. Intra-operative low-dose ketamine does not prevent a remifentanil-induced increase in morphine requirement after pediatric scoliosis surgery. Anesth Analg. 2008;107:1170-1175.

Grande LA, O'Donnell BR, Fitzgibbon DR. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient. Anesth Analg. 2008;107:1380-1383.

Troster A, Sittl R, Singler B. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 2006;105:1016-1023.

Koppert W, Sittl R, Scheuber K. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology. 2003;99:152-159.